Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

Technology

Homologous Recombination Deficiency And Hemizygosity Drive Resistance In Breast Cancer

By Nature

Study cohort and prospective sequencing The study cohort comprised 6,927 tumour samples from 5,881 patients with breast cancer. All patients underwent prospective clinical tumour and normal DNA sequencing as part of their clinical care (February 2014 ...Read more

Related Posts

OpenAI brings its Codex coding app to Windows

OpenAI brings its Codex coding app to Windows

Mar 04, 2026
Michael Pollan says AI may 'think' — but it will never be conscious

Michael Pollan says AI may 'think' — but it will never be conscious

Feb 19, 2026
Samsung Galaxy S26 vs. Google Pixel 10: The Flagship Fight That's Shockingly Close

Samsung Galaxy S26 vs. Google Pixel 10: The Flagship Fight That's Shockingly Close

Feb 27, 2026
Apple Could Launch at Least Five New Products, Including iPhone 17E, Next Week

Apple Could Launch at Least Five New Products, Including iPhone 17E, Next Week

Feb 23, 2026
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.